Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
How Drupal enhances revenues for hi-tech enterprises
If you as an enterprise need to deliver a mind-boggling amount of information and content to anyone who matters for your revenue and brand-building efforts
How to choose an affordable CMS website developer (specific to Drupal 7)
A little research will show up hundreds of well known sites across the world that have been developed by boutique Drupal organisations. Which is why, in the Drupal world, evidence of high-quality…
Digital Strategy for Startups - Choosing the best open source CMS
We provide user case scenarios & suggest the best open source CMS for startups. You will gain an unbiased view of which niche open source CMS would best serve
Digital Strategy for Startups - Choosing affordable site building software
As a startup, you might feel anxious thinking about the costs of website building software, and worry about having to change to more complex software later on.
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
